Current Status of Intramyocardial Bone Marrow Stem Cell Transplantation

Seminars in Thoracic and Cardiovascular Surgery

Volumn 20, Issue 2, 2008, Pages 119-125

  Kaminski, Alexander ^a   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

AC133; bone marrow; cardiac regeneration; intramyocardial; mesenchymal stem cell; myocardial infarction

Indexed keywords

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CELL DIFFERENTIATION; CELL HOMING; CELL SELECTION; CLINICAL EFFECTIVENESS; CLINICAL STUDY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PATIENT SAFETY; SURGICAL RISK; TREATMENT INDICATION;

ANIMALS; BONE MARROW TRANSPLANTATION; HEART FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 49049112041     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2008.03.003     Document Type: Article

References (42)

1. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
2. Murry C.E., Soonpaa M.H., Reinecke H., et al. Hematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 607-608
3. Segers V.F., and Lee R.T. Stem-cell therapy for cardiac disease. Nature 451 (2008) 937-942
4. Hodgson D.M., Behfar A., Zingman L.V., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287 (2004) H471-H479
5. Nussbaum J., Minami E., Laflamme M.A., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21 (2007) 1345-1357
6. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
7. Schuleri K.H., Boyle A.J., and Hare J.M. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol 180 (2007) 195-218
8. Li W., Ma N., Ong L.L., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25 (2007) 2118-2127
9. Berry M.F., Engler A.J., Woo Y.J., et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290 (2006) H2196-H2203
10. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial-myocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102 (2005) 11474-11479
11. Makkar R.R., Price M.J., Lill M., et al. Intramyocardial-myocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 10 (2005) 225-233
12. Breitbach M., Bostani T., Roell W., et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110 (2007) 1362-1369
13. Vieyra D.S., Jackson K.A., and Goodell M.A. Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev 1 (2005) 65-69
14. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
15. Tse H.F., Yiu K.H., and Lau C.P. Bone marrow stem cell therapy for myocardial angiogenesis. Curr Vasc Pharmacol 5 (2005) 103-112
16. Ma N., Ladilov Y., Moebius J.M., et al. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells. Cardiovasc Res 1 71 (2006) 158-169
17. Ayach B.B., Yoshimitsu M., Dawood F., et al. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc Natl Acad Sci USA 103 (2006) 2304-2309
18. Kaminski A., Ma N., Donndorf P., et al. Endothelial NOS is required for SDF-1alpha/CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells. Lab Invest 88 (2008) 58-69
19. Abbott J.D., Huang Y., Liu D., et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300-3305
20. Müller-Ehmsen J., Krausgrill B., Burst V., et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41 (2006) 876-884
21. Ohnishi S., Yanagawa B., Tanaka K., et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol 42 (2007) 88-97
22. Dhein S., Garbade J., Rouabah D., et al. Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure. J Cardiothorac Surg 1 (2006) 17
23. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
24. Fernandes S., Amirault J.C., Lande G., et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc Res 69 (2006) 348-358
25. Ye L., Haider H.K., and Sim E.K. Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. Exp Biol Med (Maywood) 231 (2006) 8-19
26. Patel A.N., Geffner L., Vina R.F., et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 130 (2005) 1631-1638
27. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
28. Tse H.F., Kwong Y.L., Chan J.K., et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
29. Stamm C., Kleine H.D., Westphal B., et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 52 (2004) 152-158
30. Nagamine H., Watanabe G., Shiobara S., et al. Intramyocardial CD34+ cell transplantation combined with off-pump coronary artery bypass grafting. Heart Surg Forum 7 (2004) E285-E287
31. Klein H.M., Ghodsizad A., Borowski A., et al. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases. Heart Surg Forum 7 (2004) E416-E419
32. Pompilio G., Cannata A., Peccatori F., et al. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 78 (2004) 1808-1812 discussion 1812-1813
33. Tse H.F., Thambar S., Kwong Y.L., et al. Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol 98 (2006) 60-62
34. Tse H.F., Thambar S., Kwong Y.L., et al. Comparative evaluation of long-term clinical efficacy with catheter-based percutaneous intramyocardial autologous bone marrow cell implantation versus laser myocardial revascularization in patients with severe coronary artery disease. Am Heart J 154 (2007) 982.e1-982.e6
35. Stamm C., Kleine H.D., Choi Y.H., et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133 (2007) 717-725
36. Ahmadi H., Baharvand H., Ashtiani S.K., et al. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction. Curr Neurovasc Res 4 (2007) 153-160
37. Davydenko V.V., Gretsenko V.V., Afanas'ev B.V., et al. Intracardial transplantation of mononuclear cells of the autologous bone marrow in complex treatment of patients with valvular heart diseases. Vestn Khir Im I I Grek 166 (2007) 16-21
38. Lunde K., Solheim S., Aakhus S., et al. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 154 (2007) 710.e1-710.e8
39. Ghodsizad A., Klein H.M., Borowski A., et al. Intraoperative isolation and processing of BM-derived stem cells. Cytotherapy 6 (2004) 523-526
40. Pompilio G., Steinhoff G., Liebold A., et al. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg 56 (2008) 71-76
41. Klein H.M., Ghodsizad A., Marktanner R., et al. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surgery Forum 10 (2007) E66-E69
42. Hagège A.A., Marolleau J.P., Vilquin J.T., et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114 suppl 1 (2006) I108-I113